42 related articles for article (PubMed ID: 24784871)
1. Targeted therapy: Generic imatinib - impact on frontline and salvage therapy for CML.
Gorkin L; Kantarjian H
Nat Rev Clin Oncol; 2016 May; 13(5):270-2. PubMed ID: 27098218
[TBL] [Abstract][Full Text] [Related]
2. Notes on some Cases of Myelogenic Leukæmia.
Hall AJ
Proc R Soc Med; 1915; 8(Med Sect):19-28. PubMed ID: 19978791
[No Abstract] [Full Text] [Related]
3. Spleno-myelogenic Leukæmia.
Riviere C
Proc R Soc Med; 1914; 7(Clin Sect):131-3. PubMed ID: 19977530
[No Abstract] [Full Text] [Related]
4. Hepatitis A induced hemophagocytic syndrome.
Saxena P; Bihari C; Rastogi A; Sood V; Khanna R; Alam S; Sarin SK
Trop Gastroenterol; 2014; 35(2):122-4. PubMed ID: 25470879
[No Abstract] [Full Text] [Related]
5. Primary pseudotumor cerebri syndrome in a young obese African woman.
Molobe LT; Shifa J; Silava C; Mojela K; Cainelli F; Vento S
Isr Med Assoc J; 2014 Sep; 16(9):595-6. PubMed ID: 25351024
[No Abstract] [Full Text] [Related]
6. Waldenström macroglobulinaemia and intestinal lymphangiectasia.
Cooke RE; Kalnins RM; Ho WK
Br J Haematol; 2014 Nov; 167(3):292. PubMed ID: 25039993
[No Abstract] [Full Text] [Related]
7. A topical matter: toxic epidermal necrolysis.
Ladizinski B; Sankey C
Am J Med; 2014 Oct; 127(10):931-2. PubMed ID: 24950488
[No Abstract] [Full Text] [Related]
8. A 5-year-old boy with miliary and osteoarticular tuberculosis.
Washington CH; Oberdorfer P
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872489
[TBL] [Abstract][Full Text] [Related]
9. Liver cancer concurrent with chronic myelocytic leukemia and extreme thrombocytosis: a rare case report.
Han P; Han ZQ; Mao X; Wang J; Li QL; Xiao M; Meng L; Tian DA; Hong ZY
J Int Med Res; 2022 Sep; 50(9):3000605221123684. PubMed ID: 36151757
[TBL] [Abstract][Full Text] [Related]
10. Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another case after orthotopic heart transplantation.
Oberender C; Kleeberg L; Nienhues N; Gresse M; Dörken B; Riess H; le Coutre P
Case Rep Hematol; 2014; 2014():890438. PubMed ID: 25478254
[TBL] [Abstract][Full Text] [Related]
11. Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy.
Sayar H; Sharfuddin AA; Taber TE; Mehta R
Exp Clin Transplant; 2011 Oct; 9(5):336-9. PubMed ID: 21967261
[TBL] [Abstract][Full Text] [Related]
12. Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used?
Mauro MJ; Maziarz RT
Mayo Clin Proc; 2006 Mar; 81(3):404-16. PubMed ID: 16529146
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging treatment options in chronic myeloid leukemia.
Jabbour E; Cortes JE; Giles FJ; O'Brien S; Kantarjian HM
Cancer; 2007 Jun; 109(11):2171-81. PubMed ID: 17431887
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of Chronic Myelogenic Leukemia (CML) with imatinib after renal transplantation.
Eishei Oskuei A; Makhdoomi K; Abkhiz S; Vossoghian S; Farrokhpour M
Arch Iran Med; 2014 May; 17(5):388-90. PubMed ID: 24784871
[TBL] [Abstract][Full Text] [Related]
15. Complete cytogenietic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation.
Koca E; Cetiner D; Goker H; Aksu S; Ozcebe OI; Haznedaroglu IC; Turgan C
Clin Nephrol; 2005 Oct; 64(4):324-6. PubMed ID: 16240908
[No Abstract] [Full Text] [Related]
16. Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML).
Tsapas A; Vlachaki E; Sarigianni M; Klonizakis F; Paletas K
Leuk Res; 2008 Apr; 32(4):674-5. PubMed ID: 17920117
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]